Non-drug evidence map · Supplements and nutraceuticals

NAD+ precursors (nicotinamide riboside, NMN)

25 registered trials across 20 conditions, from ClinicalTrials.gov.

  1. Research Tracker
  2. Non-drug evidence map
  3. NAD+ precursors (nicotinamide riboside, NMN)

Supplements intended to raise NAD+ levels, such as nicotinamide riboside. This page lists the registered trials that test it, condition by condition, with each trial's status on ClinicalTrials.gov.

25registered trials
20conditions
11completed
4with results posted
5recruiting as of 2026-11-16
⚠️
Research information, not medical advice. These pages index what has been studied in registered trials. A trial existing, completing or posting results says nothing on its own about whether an approach works or is safe for you. Supplements and devices can interact with medicines. Discuss any change with your own clinician.

Trials by condition

Sorted by number of trials. Within a condition, trials with posted results come first, then completed, recruiting and active ones. The condition name opens its evidence-gap map.

ConditionTrialsCompletedResults postedRecruitingRandomisedLargest trial (participants)
Long COVID
Show trials
33 10 2310
Obesity
Show trials
32 11 3124
Amyotrophic Lateral Sclerosis
Show trials
20 00 1380
Chronic Kidney Disease
Show trials
20 00 2118
Heart Failure
Show trials
21 10 232
Myelodysplastic Syndrome
Show trials
20 02 180
Parkinson Disease
Show trials
22 00 2410
Breast Cancer
Show trials
10 10 05
Cervical Cancer
Show trials
10 10 05
Diabetic Neuropathy
Show trials
10 00 110
Glaucoma
Show trials
10 01 1138
Huntington Disease
Show trials
10 01 1120
Metabolic Dysfunction-Associated Steatohepatitis
Show trials
11 00 1124
Osteoporosis
Show trials
11 00 1120
Ovarian Cancer
Show trials
10 10 05
Peripheral Arterial Disease
Show trials
11 00 08
Polycystic Ovary Syndrome
Show trials
11 00 188
Primary Sclerosing Cholangitis
Show trials
10 00 015
Sarcopenia
Show trials
10 00 174
Type 2 Diabetes Mellitus
Show trials
11 00 1124

What these trials measure

Primary outcomes, grouped by keyword rules: Inflammation and other biomarkers (6), Symptom severity and disease activity (3), Feasibility, adherence and safety (3), Pain (2), Cognition (2), Physical function and exercise capacity (2), Clinical events, survival and healthcare use (1), Quality of life (1), Fatigue and energy (1), Sleep (1), Heart rate, blood pressure and autonomic (1).

Names used for this class in the registry

nicotinamide riboside, nicotinamide riboside (nr), niagen, eh301 (nicotinamide riboside/pterostilbene), nad+, nmn, nicotinamide riboside 1g (oral), nmn intervention

Download all 25 trials (CSV) All non-drug classes

Related in Supplements and nutraceuticals: Vitamin D · Omega-3 fatty acids and fish oil · Probiotics, prebiotics and synbiotics · Coenzyme Q10 · N-acetylcysteine · Magnesium · Zinc · Melatonin · Creatine · Vitamin C · B vitamins and folate · Curcumin and other polyphenols · Amino acids and protein supplements · Herbal medicines and traditional formulas · Other vitamins, minerals and multivitamins · Other supplements and nutraceuticals

Source: ClinicalTrials.gov, searched 2026-11-16. Classification rules and exclusions: how this map is built.